Cytogen, Prostagen Inc., Boehringer Mannheim GmbH, Pacific Northwest Research Foundation deal

CYTO granted two licenses related to its Prostate Specific Membrane Antigen ( PSMA) technology.

Prostagen received

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE